Clinical trial · Observational
Quality of Life and Sexuality in Patients With Prostate Cancer
Quality of Life and Sexuality in Patients Treated With Radical Radiotherapy for Prostate Cancer
NCT02961686CI-TRIAL-00039623withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): None patient was enrolled
Summary
Brief summary (as posted)
The trial is to describe quality of life in patients affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patients affected by prostate cancer | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with prostate cancer
- description
- Patients affected by prostate cancer and treated with a multidisciplinary approach that comprise exclusive radiotherapy, psychological and andrologic evaluation.
- interventionNames
- Radiation: Patients affected by prostate cancer
Primary outcomes (1)
- measure
- Quality of life measurement
- timeFrame
- 2.5 years
- description
- Evaluation of the quality of life with FACT-P test in patient affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18-75 years. * Histologically-proven of prostate cancer * Indication to radical radiotherapy on prostate/ prostate + seminal vesicles / prostate + seminal vesicles + pelvic lymph nodes * Informed consent Exclusion Criteria: * Other coexisting malignancies, uncontrolled intercurrent illness, active infectious processes, and exudative, bloody, or cytologically malignant effusions excluded patients from the trial. * Previous surgery for prostate cancer, severe cardiac or vascular pathology * Other major surgery in the preceding year or currently undergoing psychiatric care or psychological counseling.
References
Publications (0)
Data not yet available
No reference posted for this study.